Brighthouse Financial, Inc. is a US-listed company in the life & health insurance industry. Its financial year ends in December.
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months to June 2026 was $6.65bn, up 2.6% on a year earlier, faster than -16.2% a quarter earlier. The diluted share count is down 2.6% on a year earlier, which lifts each remaining share.
Our model value for Brighthouse Financial is under review, so past values are not shown until it is resolved.
Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Where it stands out: change in growth rate of +18.8pp ranks 2 of 18 life & health insurance companies we cover. Where it lags: revenue growth of 2.6% ranks 16 of 18 life & health insurance companies we cover.
Current signal Revenue growth accelerating: TTM revenue growth rose to 2.6% (+18.8pp vs the prior quarter).
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
No model value for Brighthouse Financial, Inc. at the moment. Current status: valuation models disagree too widely to rate. Available reported financials are shown below.
The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.
We value Brighthouse Financial, Inc. as an insurer, with every model that fits that kind of business. Cost of equity 9.1%: the 10-year Treasury yield (4.9%) plus a beta of 0.92 times a 4.5% equity risk premium.
| Model | Value per share | In the combined value? |
|---|---|---|
| Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. | ~$80 ~$52–$130 | Primary model, counts double |
| Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. | ~$70 ~$60–$84 | Included |
| Price-to-book vs return on equity (peers) The price-to-book that peers with this return on equity trade on, from a line fitted across peers. | ~$140 ~$65–$220 | Included |
| Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. | ~$0.5 ~$88–$230 | Left out: out of range vs price (0.01x) |
| Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. | ~$160 ~$120–$210 | Included |
| Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. | — | Does not apply: This model is withheld pending its input or assumption review. |
| Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. | — | Combined value withheld. Review the individual models and their assumptions. |
Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Brighthouse Financial, Inc. with life and health insurers in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.
Weak moat
How hard Brighthouse Financial's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
Net income has been a median 0.1% of total assets over 10 years.
Net margin has been a median 2.3%; its worst year was -150.0%.
The diluted share count fell 35.0% over five years.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (25 before it).
Next results: November 5, 2026, after the close. Analysts expect revenue of $2.2bn and EPS of $4.94 (range $4.75 to $5.00) for the quarter.
| Fiscal year | EPS | Growth | Revenue | Growth |
|---|---|---|---|---|
| Current | $19.06 | −32% | $8.6bn | −0% |
| Next | $20.08 | +5% | $8.8bn | +2% |
Next year's EPS estimate has moved +1.5% in 90 days, across 4 analysts.
The consensus EPS forecast for the current fiscal year is −2.8% on 90 days ago. In the last 30 days, 1 analyst raised Brighthouse Financial, Inc.'s forecast and 1 cut it.
Average of analysts' published estimates (third-party data).
| Period | Current fiscal year | Next fiscal year |
|---|---|---|
| 90 days ago | $19.60 | $19.77 |
| 60 days ago | $18.41 | $20.14 |
| 30 days ago | $18.41 | $20.14 |
| 7 days ago | $19.02 | $20.14 |
| Now | $19.06 | $20.08 |
| Quarter to | Estimate | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | $4.77 | $4.45 | −6.7% |
| Mar 2026 | $4.47 | $4.35 | −2.6% |
| Dec 2025 | $5.19 | $3.70 | −28.7% |
| Sept 2025 | $5.03 | $4.54 | −9.7% |
Adjusted EPS as companies report it, against the average analyst estimate.
Last 12 months −23.7%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $6.5bn | $6.7bn | +2.6% |
| Net margin | 10.2% | 12.5% | +22.0% |
| P/E multiple | 5.1x | 3.0x | −40.6% |
| Share count | 59m | 58m | +2.7% |
Biggest factor: p/e multiple.
Last 3 years −10.5%
| Part | Then | Now | Effect |
|---|---|---|---|
| Revenue (last 12 months) | $2.5bn | $6.7bn | +161.9% |
| P/S multiple | 1.3x | 0.4x | −71.5% |
| Share count | 69m | 58m | +19.7% |
Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.
| Calendar year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 to date |
|---|---|---|---|---|---|---|
| Return | ||||||
| BHF | +43% | −1% | +3% | −9% | +35% | −33% |
| Industry peers (median) | +16% | −4% | +20% | +28% | +9% | +15% |
| S&P 500 | +29% | −18% | +26% | +25% | +18% | +11% |
| Months that ended higher | ||||||
| BHF | 58% | 33% | 58% | 33% | 50% | 27% |
| S&P 500 | 75% | 42% | 67% | 75% | 75% | 46% |
| Largest fall from a high during the year | ||||||
| BHF | −18% | −35% | −34% | −24% | −31% | −36% |
| S&P 500 | −5% | −25% | −10% | −8% | −19% | −9% |
Worst fall since July 17, 2017: 77% from July 17, 2017 to March 20, 2020. Getting back needed a 333% gain, and the shares have not yet recovered.
| Results released | Next day | S&P 500 next day | 5 days | 21 days |
|---|---|---|---|---|
| August 5, 2026 | −0.8% | −0.4% | −4.6% | −14.3% |
| May 6, 2026 | −1.7% | +1.1% | −2.3% | −0.1% |
| February 23, 2026 | −3.2% | −0.3% | −6.3% | −5.7% |
| November 7, 2025 | +0.3% | +1.7% | +0.1% | −0.4% |
| November 6, 2025 | +27.4% | −1.0% | +27.0% | +26.1% |
| August 7, 2025 | −6.2% | +0.7% | −1.7% | −8.6% |
| May 8, 2025 | +0.6% | +0.6% | +2.2% | +0.8% |
| February 11, 2025 | −0.8% | −0.2% | +6.8% | −9.6% |
| November 7, 2024 | −4.5% | +1.2% | −3.4% | −5.3% |
| August 7, 2024 | −4.1% | +1.6% | −6.0% | −3.9% |
| May 7, 2024 | −9.8% | +0.1% | −9.3% | −15.5% |
| February 12, 2024 | −11.5% | −1.4% | −9.6% | −9.6% |
Source: SEC EDGAR filings. Retrieved October 20, 2026.
| Period | Revenue (TTM) |
|---|---|
| FY23 Q3 | $2.6B |
| FY23 Q4 | $4.1B |
| FY24 Q1 | $2.9B |
| FY24 Q2 | $4.1B |
| FY24 Q3 | $4.9B |
| FY24 Q4 | $4.7B |
| FY25 Q1 | $7B |
| FY25 Q2 | $6.5B |
| FY25 Q3 | $6.3B |
| FY25 Q4 | $6.8B |
| FY26 Q1 | $5.9B |
| FY26 Q2 | $6.7B |
Source: SEC EDGAR filings. Retrieved October 20, 2026.
| Period | Revenue growth, TTM YoY |
|---|---|
| FY23 Q3 | -46.5% |
| FY23 Q4 | -15.3% |
| FY24 Q1 | -29.6% |
| FY24 Q2 | 60.2% |
| FY24 Q3 | 89.9% |
| FY24 Q4 | 14.7% |
| FY25 Q1 | 142.2% |
| FY25 Q2 | 59.3% |
| FY25 Q3 | 27.7% |
| FY25 Q4 | 43.2% |
| FY26 Q1 | -16.2% |
| FY26 Q2 | 2.6% |
| Fiscal year | 2015 Dec 2015 | 2016 Dec 2016 | 2017 Dec 2017 | 2018 Dec 2018 | 2019 Dec 2019 | 2020 Dec 2020 | 2021 Dec 2021 | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 | LTM Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||
| Revenue | 8,891 | 3,018 | 6,842 | 8,965 | 6,554 | 8,503 | 4,976 | 6,873 | 4,117 | 4,724 | 6,766 | 6,654 |
| Net income | 1,119 | −2,939 | −378 | 865 | −740 | −1,061 | 1,643 | 3,879 | −1,112 | 388 | 433 | 831 |
| Diluted EPS | — | −$24.54 | −$3.16 | $7.21 | −$6.76 | −$11.58 | $18.39 | $51.30 | −$18.39 | $4.64 | $5.71 | $14.39 |
| Growth (year on year) | ||||||||||||
| Revenue | — | −66.1% | +126.7% | +31.0% | −26.9% | +29.7% | −41.5% | +38.1% | −40.1% | +14.7% | +43.2% | +2.6% |
| Net income | — | −362.6% | — | — | −185.5% | — | — | +136.1% | −128.7% | — | +11.6% | +25.2% |
| Diluted EPS | — | — | — | — | −193.8% | — | — | +179.0% | −135.8% | — | +23.1% | +28.5% |
| Margins | ||||||||||||
| Net margin | 12.6% | −97.4% | −5.5% | 9.6% | −11.3% | −12.5% | 33.0% | 56.4% | −27.0% | 8.2% | 6.4% | 12.5% |
| Cash flow | ||||||||||||
| Cash from operations | 4,631 | 3,736 | 3,396 | 3,062 | 1,828 | 888 | 641 | −1,228 | −137 | −290 | 259 | −538 |
| Stock-based pay | — | — | — | — | 21 | 21 | 23 | 22 | 29 | 23 | 42 | — |
| Balance sheet | ||||||||||||
| Cash | 1,570 | 5,228 | 1,857 | 4,145 | 2,877 | 4,108 | 4,474 | 4,115 | 3,851 | 5,045 | 5,387 | 7,105 |
| Total debt | 0 | 2,797 | 3,612 | 3,963 | 4,365 | 3,436 | 3,157 | 3,156 | 3,156 | 3,155 | 3,155 | 3,154 |
| Net debt (negative = net cash) | −1,570 | −2,431 | 1,755 | −182 | 1,488 | −672 | −1,317 | −959 | −695 | −1,890 | −2,232 | −3,951 |
| Diluted shares | — | 120m | 120m | 120m | 113m | 95m | 84m | 74m | 66m | 62m | 58m | 58m |
| Returned to shareholders | ||||||||||||
| Dividends | 699 | 556 | 0 | — | — | — | — | — | — | — | — | — |
| Buybacks | — | 0 | 0 | 105 | 442 | 473 | 499 | 488 | 250 | 250 | 102 | 0 |
| Total returned | 699 | 556 | 0 | 105 | 442 | 473 | 499 | 488 | 250 | 250 | 102 | 0 |
| Quarter | 2024 Q3 Sept 2024 | 2024 Q4 Dec 2024 | 2025 Q1 Mar 2025 | 2025 Q2 Jun 2025 | 2025 Q3 Sept 2025 | 2025 Q4 Dec 2025 | 2026 Q1 Mar 2026 | 2026 Q2 Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Income | ||||||||
| Revenue | 2,018 | 1,205 | 2,390 | 871 | 1,816 | 1,689 | 1,527 | 1,622 |
| Net income | 176 | 671 | −268 | 85 | 479 | 137 | −766 | 981 |
| Diluted EPS | $2.47 | $10.46 | −$5.04 | $1.02 | $7.89 | $1.93 | −$13.82 | $16.53 |
| Growth (year on year) | ||||||||
| Revenue | +72.5% | −13.9% | +>999% | −39.0% | −10.0% | +40.2% | −36.1% | +86.2% |
| Net income | −63.3% | — | — | +150.0% | +172.2% | −79.6% | — | +>999% |
| Diluted EPS | −64.2% | — | — | +750.0% | +219.4% | −81.5% | — | +>999% |
| Margins | ||||||||
| Net margin | 8.7% | 55.7% | −11.2% | 9.8% | 26.4% | 8.1% | −50.2% | 60.5% |
| Cash flow | ||||||||
| Cash from operations | 24 | −118 | 146 | −1 | 117 | −3 | −221 | −431 |
| Last 12 months unless stated | BHF | JXN | GL | FG | GNW | MFC | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $6.7bn | $6.5bn | $6.2bn | $6.1bn | $7.4bn | $5.8bn | $11.1bn |
| Revenue growth, last 12 months | 2.6% | 15.1% | 5.2% | 15.0% | 2.1% | 5.0% | 6.1% |
| Revenue growth, 3-year average | 37.8% | 43.4% | 5.5% | 19.4% | −0.3% | — | 4.9% |
| Revenue growth, latest quarter | 86.2% | −22.6% | 8.0% | 4.2% | 5.8% | — | 6.9% |
| Operating margin | — | — | 24.0% | — | 0.4% | — | 12.3% |
| Operating margin, 3-year average | — | — | 25.1% | — | 4.2% | — | 15.0% |
| Net margin | 12.5% | 1.6% | 19.6% | 6.9% | 2.9% | 68.5% | 6.5% |
| Cash from operations / revenue | −8.1% | 90.9% | 22.5% | 71.5% | 5.8% | 394.9% | 14.6% |
| Free-cash-flow margin | — | 90.9% | 19.9% | 59.9% | 2.8% | 390.5% | 19.4% |
| Free-cash-flow margin, 3-year average | — | 106.8% | 22.2% | 86.7% | 0.7% | 152.8% | 21.3% |
| Stock pay / revenue | — | 1.6% | 0.9% | 0.6% | 0.9% | 0.0% | 0.8% |
| Change in share count | −2.6% | −5.8% | −5.3% | 2.7% | −6.5% | −4.3% | −4.7% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | 2.6% | 7.0% | 16 of 18 |
| Change in growth rate Growth | +18.8pp | +1.5pp | 2 of 18 |
| Net margin Profitability | 12.5% | 6.9% | 5 of 18 |
| Change in share count Balance sheet | -2.6% | -4.7% | 13 of 16 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Annuities | $3.6B | 53.8% | ▲ 88.3% |
| Runoff | $1.3B | 18.8% | ▲ 27.9% |
| Life | $1.1B | 17.0% | ▲ 3.2% |
| Corporate and Other | $705M | 10.4% | ▲ 3.2% |
From Brighthouse Financial, Inc.'s 10-K filed February 24, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Blackrock, Inc. | $341M | 5.4M | 10.3% | ▲ 2.3% |
| UBS Group AG | $266M | 4.2M | 8.0% | ▲ 12.5% |
| Dimensional Fund Advisors LP | $230M | 3.6M | 6.9% | ▲ 2.2% |
| Dme Capital Management, LP | $180M | 2.8M | 5.4% | 0.0% |
| American Century Companies Inc | $168M | 2.7M | 5.1% | ▲ 2.4% |
| Vanguard Capital Management LLC | $164M | 2.6M | 5.0% | ▲ 1.1% |
| Vanguard Portfolio Management LLC | $158M | 2.5M | 4.8% | ▼ 0.3% |
| State Street Corp | $132M | 2.1M | 4.0% | ▲ 7.4% |
| Morgan Stanley | $119M | 1.9M | 3.6% | ▲ 45.9% |
| Millennium Management LLC | $77.1M | 1.2M | 2.3% | ▼ 20.2% |
| Soros Fund Management LLC | $70.7M | 1.1M | 2.1% | ▲ 31.8% |
| Geode Capital Management, LLC | $69.6M | 1.1M | 2.1% | ▼ 0.1% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Brighthouse Financial, Inc.'s complete shareholder register. Values are as reported by the filers ; 5 inconsistently scaled filing rows were excluded.
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
No trades in Brighthouse Financial, Inc. disclosed in the last 12 months; 8 earlier trades on record.
Next expected around November 4, 2026 estimated from the company's past filing pattern, not announced
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| Financial statements | SEC 10-K and 10-Q filings | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
